X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/26/2852737/0/en/Humacyte-to-Host-Virtual-KOL-Event-Hemodialysis-Access-A-Crossroads-of-Care-on-March-28-2024.html
https://www.globenewswire.com/news-release/2024/03/22/2850868/0/en/Humacyte-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/18/2847721/0/en/Humacyte-to-Present-2023-Fourth-Quarter-and-Year-End-Financial-Results-and-Provide-Corporate-Update-on-March-22-2024.html
https://www.globenewswire.com/news-release/2024/03/18/2847721/0/en/Humacyte-to-Present-2023-Fourth-Quarter-and-Year-End-Financial-Results-and-Provide-Corporate-Update-on-March-22-2024.html
https://www.globenewswire.com//news-release/2024/03/01/2838873/0/en/Humacyte-Inc-to-Present-at-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/03/01/2838544/0/en/Humacyte-Inc-Announces-Pricing-of-40-2-Million-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/02/29/2838372/0/en/Humacyte-Inc-Announces-Proposed-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/02/09/2826784/0/en/Human-Acellular-Vessel-HAV-Biologics-License-Application-Granted-Priority-Review-by-U-S-FDA-for-the-Treatment-of-Vascular-Trauma.html
https://www.globenewswire.com//news-release/2023/12/12/2794704/0/en/Humacyte-Submits-Biologics-License-Application-BLA-to-U-S-FDA-Seeking-Approval-of-Human-Acellular-Vessel-HAV-for-the-Treatment-of-Vascular-Trauma.html
https://www.globenewswire.com//news-release/2023/11/17/2782541/0/en/Humacyte-Announces-Two-Presentations-at-the-VEITHsymposium-of-Positive-Clinical-Results-of-the-Human-Acellular-Vessel-HAV-in-the-Treatment-of-Vascular-Trauma.html
Market Place
Share 
